Orthofix Medical Inc. Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings
Orthofix Medical Inc. (OFIX) reported Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings of $5.58 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings · last filed 2019-02-25
- Orthofix Medical Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2017 was $5.58M, a 104.80% increase from fiscal 2016.
- Orthofix Medical Inc. other-than-temporary impairment loss, debt securities, available-for-sale, recognized in earnings for fiscal 2016 was $2.73M.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings 12 month |
|---|---|
| 2017-12-31 | $5.58M 10-K · filed 2019-02-25 |
| 2016-12-31 | $2.73M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |